NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Alto Neuroscience, Inc. (NYSE: ANRO). Shareholders who purchased shares of ANRO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/alto-neuroscience-inc-loss-submission-form/?id=161036&from=3 CLASS PERIOD: T ...

NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Sarepta Therapeutics, Inc. (NASDAQ: SRPT). Shareholders who purchased shares of SRPT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/sarepta-loss-submission-form/?id=161034&from=3 CLASS PERIOD: June 22, 2 ...

NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Petco Health and Wellness Company, Inc. (NASDAQ: WOOF). Shareholders who purchased shares of WOOF during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/petco-loss-submission-form/?id=161035&from=3 CLASS PERIOD: ...

Kroger's ex-CEO mysteriously resigned from the supermarket giant earlier this year — and now, thanks to a nearly two-year-old lawsuit that the singer-songwriter Jewel is behind, he's been ordered to reveal the reason for his exit. Attorneys for Rodney McMullen have argued in recent court documents that his March resignation has absolutely nothing to do with the "You Were Meant For Me" singer's 2023 contract breach lawsuit against Kroger and questions about it in a deposition are aimed at "annoying and emba ...

Join for a 100% Risk-Free trial and see if our proven method can help you too. You do not need to pay for the costly lessons from the market itself.My last coverage on the iShares International Select Dividend ETF (BATS: IDV ) dates back to Nov 2023. The title of the article, "VYM Vs. IDV: Why We Prefer U.S. Over International,” alreadySensor Unlimited contributes to the investing group Envision Early Retirement which is led by Sensor Unlimited. They offer proven solutions to generate both high income and h ...

First Half 2025 Net Income Available to Common Shareholders Expected to be in the Range of $125.0 Million to $145.0 Million, or $4.08 to $4.74 Diluted Net Income per Common ShareAs of June 30, 2025, Estimated Cash of $268 Million, Total Debt of $1.46 Billion, and Net Debt in the Range of $809 Million to $839 Million; Total Debt Estimated to Have Decreased by $600 Million from September 30, 2024; Net Debt Estimated to Have Decreased by $544 Million to $574 Million from September 30, 2024Preliminary Year-End ...

NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between May 7, 2025 and July 28, 2025, both dates inclusive (the “Class Period”), of the important September 30, 2025 lead plaintiff deadline. SO WHAT: If you purchased Novo Nordisk securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHA ...

West Vancouver, British Columbia--(Newsfile Corp. - August 13, 2025) - K9 Gold Corp. (TSXV: KNC) (FSE: 5GP0) (OTCQB: WDFCF) ("K9" or the "Company") is pleased to announce that it has closed its previously announced non-brokered private placement (the "Offering") for total gross proceeds of $400,000.Under the Offering, the Company issued 4,000,000 units (the "Units") at a price of $0.10 per Unit. Each Unit consists of one common share of the Company and one common share purchase warrant (a "Warrant"). Each ...

Webcast and Conference Call Scheduled for 5:00 PM ETNEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), a leading provider of wellness solutions for people on the go, today announced that it will report second quarter 2025 financial results on Thursday, August 14, 2025, after the market close. The announcement will be followed by a webcast and conference call at 5:00 p.m. ET. The Company encourages investors, and interested parties, to listen via webcast, as th ...

- Positive 12-month Phase 1/2 clinical data in adult cohort and early pediatric clinical data support potential for meaningful vision restoration with OPGx-LCA5 -- FDA grants Regenerative Medicine Advanced Therapy (RMAT) designation for OPGx-LCA5 - - Positive topline results reported from VEGA-3 and LYNX-2 Phase 3 trials with Phentolamine Ophthalmic Solution 0.75% - - OPGx-BEST1 on track to enter Phase 1/2 trial in H2 2025 for the treatment of bestrophin-1 related inherited retinal disease - - Non-dilutive ...